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Abstract
The transport of L-leucine, L-phenylalanine and L-alanine by the perfused lactating rat mammary gland has been examined using a rapid,
paired-tracer dilution technique. The clearances of all three amino acids by the mammary gland consisted of a rising phase followed by a
rapid fall-off, respectively, reflecting influx and efflux of the radiotracers. The peak clearance of L-leucine was inhibited by BCH (65%) and
D-leucine (58%) but not by L-proline. The inhibition of L-leucine clearance by BCH and D-leucine was not additive. L-leucine inhibited the
peak clearance of radiolabelled L-leucine by 78%. BCH also inhibited the peak clearance of L-phenylalanine (66%) and L-alanine (33%) by
the perfused mammary gland. Lactating rat mammary tissue was found to express both LAT1 and LAT2 mRNA. The results suggest that
system L is situated in the basolateral aspect of the lactating rat mammary epithelium and thus probably plays a central role in neutral amino
acid uptake from blood. The finding that L-alanine uptake by the gland was inhibited by BCH suggests that LAT2 may make a significant
contribution to neutral amino acid uptake by the mammary epithelium. D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
The lactating mammary gland requires a considerable
supply of amino acids to support protein synthesis. In this
connection, a number of amino acid transport mechanisms
have been identified in lactating mammary tissue. Na+-
dependent mechanisms which have been identified include
system A [1–6], system XAG
 [7–9] and system h [10,11].
Indeed, mRNA for two Na+-dependent anionic amino acid
transporters, namely GLAST and GLT-1, is expressed in the
rat mammary gland [12]. Other Na+-dependent systems
which have been identified in lactating mammary tissue
include two mechanisms which operate with a broad-sub-
strate specificity, one of which may be system B0,+ [5,13]. In
relation to this, mRNA encoding a Na+- and Cl-dependent
amino acid transport system with a broad-substrate specific-
ity is expressed in the human mammary gland [14]. In ad-
dition, a Na+-dependent system which accepts neutral amino
acids (but not methylaminoisobutyric acid) as substrates has
been identified in pig mammary tissue [15]. The lactating rat
mammary gland also expresses Na+-independent amino acid
transport mechanisms. There is evidence for cationic amino
acid transport in bovine, rat, mouse and porcine mammary
tissue: systems resembling y+ and y+L have been described
[16–19].
Mammary tissue also appears to express system L, thus,
neutral amino acid transport via a Na+-independent, BCH-
sensitive pathway has been found in rat and mouse mammary
tissue explants [1,4,5]. It is predicted that system L mediates
the uptake of neutral amino acids across the blood-facing
aspect of the mammary epithelium. To test this prediction, we
have investigated the transport of neutral amino acids (L-
leucine, L-phenylalanine and L-alanine) using the perfused
lactating rat mammary gland in conjunction with the rapid,
paired-tracer dilution technique. It is reasonable to assume
that the perfused mammary gland gives a measure of trans-
port across the basolateral pole of the mammary epithelium
[20]. In particular, we have looked for the presence of BCH-
sensitive neutral amino acid transport. In addition, we have
tested for the presence of LAT1 and LAT2mRNA in lactating
rat mammary tissue. LAT1 and LAT2, induce system L-like
activity when co-expressed with CD98 (formerly known as
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4F2hc). LAT1 transports neutral amino acids with branched
or aromatic side chains in a manner not dependent upon Na+
[21]. LAT2 also transports neutral amino acids in a fashion
which does not require Na+ but appears to have a wider
substrate specificity than LAT1 [22–25].
2. Methods
2.1. Animals
Lactating Wistar rats 10 days postpartum which were
suckling 8–10 pups were used in this study. The animals
were maintained on a 12 h light–12 h dark cycle and
allowed free access to water and chow.
2.2. Perfusion of the lactating rat mammary gland
The lactating rat mammary gland was perfused according
to the method described in detail by Clegg and Calvert [26].
Anaesthesia was induced and maintained throughout the
experiment by an intraperitoneal injection of sodium penta-
barbitone (40 mg/kg of body weight). A skin incision was
made from pubis to sternum. The left inguinal-abdominal
mammary tissue was freed from the abdominal musculature
and a ligature was tied around the vein communicating with
the pectoral mammary tissue. In addition, ligatures were tied
around the iliac branches of the iliolumbar artery and vein,
the external pudendal arteries and veins and the femoral
artery and vein. A second incision was made on the medial
surface of the left thigh to expose the superficial epigastric
artery and veins. Both blood vessels were cleared of fat and
connective tissue and catheterized. The body temperature of
the rat was maintained by the use of a lamp positioned
above the animal. The mammary gland was perfused via the
superficial epigastric blood vessels with a solution contain-
ing (in mM) 118 NaCl, 4 KCl, 2 CaCl2, 1 MgSO4, 1
NaH2PO4, 25 NaHCO3, 10 glucose. and 1 amino(oxy)acetic
acid. The perfusates also contained bovine serum albumin
(5% w/v) and were gassed to pH 7.4 with 95% O2/5% CO2.
Amino(oxy)acetic acid was included in the perfusates
because it has been shown that amino acids are transami-
nated within mammary tissue (e.g. see Refs. 27,28). Indeed,
experiments showed that the peak clearance of radiolabelled
L-leucine was slightly enhanced by amino(oxy)acetic acid,
suggesting that L-leucine can be rapidly metabolised in
lactating rat mammary tissue (Fig. 1). At the end of the
experiment, the perfused mammary tissue was removed
from the animal, lightly blotted and weighed.
2.3. Measurement of L-leucine, L-phenylalanine and L-
alanine transport by the perfused mammary gland
Leucine, phenylalanine and alanine transport by the
perfused rat mammary gland was measured at 37 jC using
[3H]leucine, [3H]phenylalanine and [3H]alanine, respec-
tively. The transport of the radiolabelled amino acids was
measured by a rapid, paired-tracer dilution technique as
described by Millar et al. [7]. Radiolabelled sucrose was used
as an extracellular marker. A bolus containing the radio-
labelled amino acid (21.4 ACi/ml) and [14C]sucrose (7.1 ACi/
ml) was injected close arterially (f 60 Al in < 2 s) and
venous outflow samples were collected at 6-s intervals. The
fractional uptake (U) for each collection period was calcu-
lated according to Eq. (1)
U ¼ 1 ðRt=RiÞ ð1Þ
where Rt is the ratio of radiolabelled amino acid/radiolabelled
sucrose in the venous outflow samples at time t and Ri is the
ratio of radiolabelled amino acid/radiolabelled sucrose in the
injectate. Radiolabelled amino acid clearance (i.e. the volume
of perfusate notionally cleared of isotope) was calculated by
multiplying the perfusate flow rate (Al/min per g tissue wet
weight) by the uptake (U) for each collection period.
2.3.1. RNA isolation and RT-PCR
Total cellular RNA was isolated from lactating rat mam-
mary gland using guanidinium thiocyanate and CsCl centri-
fugation [29]. RNA was resuspended in water and the
concentration determined by the A260, where 1 A260 corre-
sponds to 40 Ag of RNA. Samples of RNAwere treated with
DNase I before RT-PCR to remove contaminating DNA. The
primers used in the subsequent RT-PCR were as follows:
CD98 [21], forward, 5V-AGCGCTCTCTGTTACACGGT-3V
and reverse, 5V-CTCAGGTTTTCCAGGCTCAG-3V; LAT1
[21], forward, 5V-CTGGCCATCATCATCTCCTT-3Vand re-
Fig. 1. The clearance of L-[3H]leucine by the perfused lactating rat
mammary gland in the absence (.) and presence (n) of amino(oxy)acetic
acid. Mammary tissue was perfused with a medium containing (in mM) 118
NaCl, 4 KCl, 2 CaCl2, 1 KH2PO4, 1 MgSO4, 25 NaHCO3 and 10 glucose.
The perfusate also contained 5% BSA and was gassed to pH 7.4 with 95%
O2/5% CO2. Amino(oxy)acetic acid was used at a concentration of 1 mM.
Each point is the meanF SE of 11 and 16 experiments, respectively, in the
absence and presence of amino(oxy)acetic acid. aP < 0.05; bP < 0.01.
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verse 5V-GGACGTGAACAGAGACCCAT-3V; LAT2 [22],
forward 5V-GCTGGAAGAAGCCTGACATC-3Vand reverse,
5V-ATACAGGAACACCCGTCAGC-3V; GAPDH [30], for-
ward, 5V-GGTGATGCTGGTGCTGAGTA-3Vand reverse, 5V-
CCACAGTCTTCTGAGTGGCA-3V. The expected size of
the PCR products were 256 bp for CD98, 213 bp for LAT1,
159 bp for LAT2 and 304 bp for GAPDH. One microgram of
total RNA was reverse transcribed into cDNA using oli-
go(dT)12–18 primer. The reverse transcription reaction, con-
taining 500 AM dNTP, 25 Ag ml1 oligo(dT)12–18 primer, 10
units Al1 M-MLV reverse transcriptase, 3 mM MgCl2, 75
mM KCl, 10 mM dithiothreitol and 50 mM Tris–HCl (pH
8.3) was sequentially incubated at 25 jC for 10 min, at 42 jC
for 50 min and at 70 jC for 15 min and cooled on ice. To
control for DNA contamination, reactions were run without
RNA or with RNA in the absence of the reverse transcriptase
(no amplified product was detected, results not shown). The
synthesised cDNA (0.05 Ag equivalent to RNA) was used for
PCR amplification in a reaction mixture containing 200 AM
dNTP, 1 AM forward and reverse primers, 0.05 units Al1 Taq
DNA polymerase, 1.5 mM MgCl2, 50 mM KCl, and 20 mM
Tris–HCl (pH 8.4). The PCR conditions were; 94 jC for 3
min, 60 jC for 1 min and 72 jC for 2 min; then 30 cycles (for
CD98, LAT1 and LAT2) and 27 cycles (for GAPDH) at 94 jC
for 1 min, 60 jC for 1 min and 72 jC for 2 min followed by a
10-min final extension at 72 jC. PCR products were sepa-
rated on a 2% agarose gel which was subsequently stained
with ethidium bromide.
2.4. Materials
L-[3H]leucine (specific activity = 61 Ci/mmol), L-[3H]phe-
nylalanine (specific activity = 26 Ci/mmol), L-[3H]alanine
(specific activity = 47 Ci/mmol) and [14C]sucrose (specific
activity 56 mCi/mmol) were purchased from Amersham
International PLC, Amersham, Bucks, UK. Moloney murine
leukemia virus (M-MLV) reverse transcriptase, oligo(dT)12–
18 primer, deoxynucleotide 5V-triphosphate (dNTP) and Taq
DNA polymerase were purchased from Gibco, Paisley, UK.
Deoxyribonuclease 1 (DNase 1) was from Promega, South-
ampton, Hampshire, UK). All other chemicals including
BCH were obtained from Sigma, Poole, Dorset, UK.
2.5. Statistics
Differences were assessed by Student’s paired or unpaired
t-test as appropriate and were considered significant when
P < 0.05.
3. Results
3.1. L-leucine transport by the perfused rat mammary gland
Figs. 2 and 3 illustrate the clearance profile of radio-
labelled L-leucine by the perfused mammary gland in the
absence and presence of unlabelled L-leucine, BCH, D-
leucine and L-proline. The unlabelled compounds, when
required, were co-injected with the radiotracers. Unlabelled
amino acids were added to the bolus to give a final concen-
tration of 25 or 50 mM. Although this appears to be a high
concentration to use, it must be borne in mind that the
concentration of each unlabelled amino acid at the site of
transport would have been less owing to the diluting effect of
the perfusate. For example, Fig. 2b shows the dilution profile
for L-leucine constructed from the percentage recovery of the
extracellular marker. Under control conditions (i.e. no addi-
Fig. 2. (a) The clearance of L-[3H]leucine by the perfused rat mammary
gland in the absence (n) and presence (.) of unlabelled L-leucine. (b) The
dilution profile of unlabelled L-leucine constructed from the percentage
recovery of the extracellular marker. Mammary tissue was perfused with a
buffer containing (in mM) 118 NaCl, 5 KCl, 2 CaCl2, 1 KH2PO4, 1 MgSO4,
25 NaHCO3, 10 glucose and 1 amino(oxy)acetic acid. The perfusate also
contained 5% BSA and was gassed to pH 7.4 with 95% O2/5% CO2.
Unlabelled L-leucine, when required, was added to the bolus at a
concentration of 50 mM. The results are the meanF SE of five experiments.
bP< 0.01; cP< 0.001.
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tions), the clearance of radiolabelled leucine consisted of a
rising phase followed by a rapid fall-off (Figs. 2 and 3). The
peak clearance was reached approximately 30 s after the
isotope was injected into the superficial epigastric artery and
18 s after the appearance of tracer in the eluent. It is evident
from Fig. 2a that the inclusion of unlabelled L-leucine in the
bolus markedly changed the clearance profile of radiola-
belled L-leucine by the mammary gland: the peak clearance
was reduced by 78% from 375F 61 to 82F 8.5 Al/min/g
tissue wet weight at t = 30 s (F SE, n = 5, P < 0.01). Unla-
belled D-leucine also reduced the clearance of radiolabelled
leucine by the mammary gland but not to the same extent as
unlabelled L-leucine (Fig. 3a). Thus, the peak clearance (at
t = 30 s) was reduced by 58% from 374F 49 to 157F 22 Al/
min/g tissue wet weight (F SE, n = 5, P < 0.002). Similarly,
D-leucine at a concentration of 25 mM reduced the peak
Fig. 3. (a) The clearance of radiolabelled L-leucine by the perfused rat mammary gland in the absence (n) and presence (.) of unlabelled D-leucine. The
results are the meanF SE of five experiments. aP < 0.05; bP< 0.01; cP < 0.001. (b) The clearance of radiolabelled L-leucine by the perfused rat mammary
gland in the absence (n) and presence (.) of unlabelled BCH. The results are the meanF SE of five experiments. aP < 0.05; bP < 0.01; cP < 0.001. (c) The
clearance of radiolabelled L-leucine by the perfused rat mammary gland in the absence (n) and presence (.) of unlabelled D-leucine and BCH. The results are
the meanF SE of five experiments. aP< 0.05; bP< 0.01; cP < 0.001. (d) The clearance of radiolabelled L-leucine by the perfused rat mammary gland in the
absence (n) and presence (.) of unlabelled L-proline. The results are the meanF SE of three experiments. The composition of the perfusate was the same as
that described in Fig. 2. When required, the unlabelled amino acids were added to the bolus at a concentration of 50 mM (D-leucine, BCH) or 25 mM
(L-proline).
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clearance to the same extent as 50 mM D-leucine (results not
shown). The clearance profile of radiolabelled L-leucine by
the perfused mammary gland was also altered by the
presence of BCH (Fig. 3b). The peak clearance was reduced
by 65% from 394F 41 to 137F 17 Al/min/g tissue wet
weight (F SE, n = 5, P < 0.001). Fig. 3c shows the effect of
adding BCH and D-leucine together to the bolus (each at a
concentration of 50 mM) on the clearance of radiolabelled
L-leucine. The peak clearance was reduced by 71% from
399F 26 to 114F 12 Al/min/g tissue wet weight (F SE,
n = 5, P < 0.001). It is evident, therefore, that the effects of
BCH and D-leucine were not additive. Proline (25 mM) had
no significant effect on the peak clearance of radiolabelled
leucine by the perfused mammary gland (Fig. 3d). However,
it appears that L-proline increased the clearance of radio-
labelled L-leucine in the latter part of the time course. At
present, we have no clear explanation for this observation
except for the possibility that L-proline is affecting L-leucine
efflux from the gland.
3.2. L-phenylalanine transport by the perfused rat mammary
gland
The effect of unlabelled L-leucine and BCH on the
clearance of radiolabelled phenylalanine by the perfused
gland was examined (Fig. 4). The unlabelled amino acids
were added to the injectate at a final concentration of 50 mM.
Under control conditions (i.e. no additions), the clearance of
radiolabelled phenylalanine rose initially to reach a peak 24 s
following the injection of the bolus into the artery and
declined thereafter. Unlabelled L-leucine reduced the peak
clearance of [3H]phenylalanine by 63% from 400F 23 to
147F 9 Al/min/g tissue wet weight (F SE, n = 3, P < 0.01) at
24 s (Fig. 4a). The peak clearance of radiolabelled L-phenyl-
alanine by the perfused mammary gland was inhibited to a
similar extent by BCH (Fig. 4b). Thus, the peak clearance
was reduced by 66% from 424F 66 to 142F 24 Al/min/g
tissue wet weight (F SE, n = 4, P < 0.02) at t= 24 s.
Fig. 4. (a) The clearance of radiolabelled L-phenylalanine by the perfused
rat mammary gland in the absence (n) and presence (.) of unlabelled
L-leucine. The results are the meanF SE of three experiments. aP< 0.05;
bP< 0.01; cP < 0.001. (b) The clearance of radiolabelled L-phenylalanine by
the perfused rat mammary gland in the absence (n) and presence (.) of
unlabelled BCH. The results are the meanF SE of four experiments.
aP < 0.05. The composition of the perfusate was the same as that described in
Fig. 2. When required, L-leucine and BCH were added to the bolus at a
concentration of 50 mM.
Fig. 5. The clearance of L-[3H]alanine by the perfused rat mammary gland in
the absence (n) and presence (.) of unlabelled BCH. The composition of
the perfusate was the same as that described in Fig. 2. When required, BCH
was added to the bolus at a concentration of 50 mM. The results are the
meanF SE of five experiments. aP < 0.05; bP< 0.01.
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3.3. L-alanine transport by the perfused rat mammary gland
Fig. 5 illustrates the clearance of L-alanine by the
perfused rat mammary gland in the absence and presence
of unlabelled BCH (added to the bolus at 50 mM). L-alanine
clearance under control conditions, like that of L-leucine and
L-phenylalanine clearance, consisted of a rising phase fol-
lowed by a rapid fall-off. The peak clearance was attained
36 s after radiolabelled L-alanine was administered into the
superficial epigastric artery. It is clear from Fig. 5 that BCH
inhibited L-alanine clearance by the rat mammary gland: the
peak clearance was reduced by 33% from 384F 14 to
255F 18 Al/min/g tissue wet weight (F SE, n = 5, P < 0.01).
3.4. RT-PCR analysis of LAT1, LAT2 and CD98 mRNA in
lactating mammary tissue
To check for the presence of LAT1, LAT2 and CD98
mRNA in mammary tissue, we subjected total RNA isolated
from lactating rat mammary tissue to RT-PCR. Products of
the expected size for LAT1, LAT2 and CD98 were amplified
from rat mammary tissue (Fig. 6).
4. Discussion
The present study has shown that the perfused rat
mammary gland transports L-leucine, L-phenylalanine and
L-alanine. Each of the amino acids had a similar clearance
profile, i.e. a rising phase followed by a rapid fall-off. The
rising phase is believed to be governed by the unidirectional
uptake of the radiolabelled amino acids, whereas the fall-off
occurs because the tracers exit the cells and return to the
circulation (see Ref. 31). In addition, the finding that the
clearance profile had an initial rising phase suggests that
there is an arterio-venous shunt pathway(s) in the lactating
rat mammary gland. It is notable that the time taken to reach
the peak clearance differed for each amino acid. Thus, the
time taken to reach the peak clearance following the bolus
injection for L-phenylalanine, L-leucine and L-alanine was
24, 30 and 36 s, respectively.
4.1. Inhibition of amino acid clearances
The inhibition of radiolabelled amino acid transport by
unlabelled amino acids was examined by adding the latter
to the bolus at a concentration of 50 mM. The uptake of L-
leucine, L-phenylalanine and L-alanine was inhibited by
BCH. In this connection, it has been shown that BCH
inhibits the transport of Na+-independent a-aminoisobuty-
rate uptake in rat mammary tissue explants [4]. The present
results appear to confirm the presence of system L in rat
mammary tissue. Moreover, the present study places the
transporter in the basolateral aspect of the lactating rat
mammary epithelium given that the perfused mammary
gland preparation allows transport to be measured across
the blood-facing aspect of the epithelium. However, the
presence of system L in the apical membrane as well as the
basolateral membrane of mammary secretory cells cannot,
at this stage, be ruled out. We are aware, however, that a
portion of the BCH-sensitive amino acid uptake by the
perfused gland could be via system B0,+. This is based on
the finding that system B0,+ is inhibited by BCH [32]. In
this connection, mRNA encoding a Na+-dependent amino
acid transport system which is inhibited by BCH and thus
resembles system B0,+ has been detected in the human
(presumably non-lactating) mammary gland. However, the
finding that L-lysine uptake by lactating rat mammary tissue
is not dependent upon Na+ [17] suggests that system B0,+
may only play a relatively minor role in amino acid uptake
across the basolateral pole of the lactating rat mammary
epithelium. Moreover, system B0,+ expressed in the apical
membrane of cultured human bronchial epithelial cells
appears to accept proline as a substrate [33]. In this study,
we found no evidence for an interaction between L-leucine
uptake and proline.
It appears that the system which accepts L-leucine as a
substrate in the perfused rat mammary gland is not partic-
ularly stereospecific. This notion is based on the finding that
the BCH-sensitive portion of L-leucine transport by the
perfused mammary gland was also inhibited by D-leucine
(the effects of D-leucine and BCH were not additive). This
observation is in accordance with the earlier finding that
BCH-sensitive a-aminoisobutyrate uptake by rat mammary
tissue explants can be inhibited by D-leucine [4]. It is notable
that neither BCH nor D-leucine inhibited the clearance of
radiolabelled L-leucine to the same extent as unlabelled L-
leucine. This suggests that L-leucine can also enter mammary
cells via a pathway other than system L. The precise identity
of this pathway(s) remains to be identified. Similarly, L-
alanine and L-phenylalanine uptake across the basolateral
aspect of the mammary gland appears to be via more than one
pathway given that BCH did not completely inhibit L-alanine
Fig. 6. The detection of CD98, LAT1, LAT2 and GAPDH mRNA in
lactating rat mammary tissue using RT-PCR.
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and L-phenylalanine clearance. Uptake via system A could of
course account for part of the BCH-insensitive component of
L-alanine uptake by the rat mammary gland [4,6].
4.2. Molecular identity of system L in mammary tissue
System L has recently been characterized at the molecular
level. Two heterodimeric proteins consisting of a light chain
(LAT1 or LAT2) and a heavy chain (CD98) exhibit system
L-like activity. The light and heavy chains of the protein are
joined by a disulfide bond [34]. LAT1 and LAT2 transport
neutral amino acids, however, LAT2 has a much wider
substrate specificity than LAT1.We now show, using RT-
PCR, that lactating rat mammary tissue expresses mRNA for
both LAT1 and LAT2 (and CD98). One major distinguishing
feature between LAT1 and LAT2 is that LAT2 transports L-
alanine, whereas LAT1 does not [24,25]. On this basis, BCH-
sensitive amino acid transport across the basolateral aspect of
the mammary epithelium appears to resemble the properties
of LAT2. In this connection, Sharma and Kansal [5] have
recently shown that Na + -independent L-alanine uptake by
mouse mammary explants is inhibited by BCH. In addition,
Na + -independent AIB uptake by rat mammary tissue
explants, which is attributed to system L, is inhibited by
alanine [4]. Both of these observations appear to support a
functional role for LAT2 in the basolateral aspect of the
lactating mammary epithelium. On the other hand, the
finding that BCH-sensitive L-leucine uptake by the perfused
rat mammary gland can also be inhibited by D-leucine
reflects the properties of LAT1 rather than LAT2: D-isomers
readily interact with LAT1 but not LAT2 [25]. However,
Segawa et al. [22] have shown that L-leucine transport via
LAT2 is inhibited by certain D-isomers (i.e. D-serine, D-
alanine, D-threonine, D-cysteine). There is the possibility,
however, that amino acid uptake into lactating mammary
tissue is also facilitated by an L-type transporter distinct from
LAT1 and LAT2.
In conclusion, the present study confirms the presence of
system L in the lactating rat mammary gland and places it in
the blood-facing aspect of the lactating rat mammary epi-
thelium. This transport system may be one of the most
important pathways for the uptake of essential amino acids
by the mammary gland. The data also provide an insight into
the molecular nature of system L in the mammary gland.
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